United States · FDA National Drug Code directory
Bupropion Hydrochloride (XL)
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 77771-145_3bf617e4-22ef-4237-b80b-24c4c1b1bfda
- Product NDC
- 77771-145
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- bupropion hydrochloride
- Labeler
- RADHA PHARMACEUTICALS, INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221026
- Source listing expiry
- 20271231
Source-listed ingredients
- BUPROPION HYDROCHLORIDE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (77771-145-05) · 77771-145-05
- 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (77771-145-30) · 77771-145-30
- 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (77771-145-90) · 77771-145-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →